Our mission is to ensure the generation of accurate and precise findings.
Please enter subscribe form shortcode
Please enter instagram feed shortcode
R&D facilities
Manufacturing Facilities
Clients Served
Markets Tapped
Priyaranjan Pattanaik holds Bachelor and Master Degree in Pharmaceutical Technology from Biju Patnaik University, Bhubaneswar.
He has over 12 years of experience in formulation research. Prior to his stint with Finoso Pharma, he worked with R&D centres of Indian leading pharma companies like Micro labs, Medreich, Indoco Remedies, Hetero Labs and Optimus Pharma. He has varied experience that encompasses activities from formulation development to product approvals for the US, Canada, Europe and other regulated markets along with other emerging markets. He managed product development programs from initiation, development strategy, risk assessment analysis, infringement analysis and regulatory filings of generic products.
This will close in 0 seconds
Sanjay holds a bachelor’s degree in chemistry and a master’s degree in Analytical- chemistry from the University of Mumbai, Maharashtra, India. He brings over 21 years of experience in Analytical Research & Development, specializing in APIs and diverse finished dosage forms. Prior to joining Finoso Pharma, he worked with leading pharmaceutical organizations, including Cipla, Dr. Reddy’s Laboratories, and Aizant Drug Research Solutions Pvt. Ltd.
Â
He has extensive experience in analytical method development, validation, transfer, stability studies, and packaging material testing, with strong knowledge of regulatory compliance, including 21 CFR Part 11 and LIMS. Proficient in advanced analytical instruments such as HPLC, GC, UPLC, LC-MS, GC-MS, FTIR etc.
Â
He specializes in assay, discriminatory dissolution, related substances, nitrosamine, elemental, and genotoxic impurity testing, along with other product-specific analytical requirements across a wide range of pharmaceutical dosage forms, including solid orals, oral liquids, pellets, ophthalmic and nasal preparations, suspensions, injectables, inhalers, gels, syrups, ointments, and creams.
Â
He has proven experience in the end-to-end delivery of projects, with regulatory exposure across USFDA, EMA, MHRA, ANVISA, TGA, Health Canada, and Rest of World (ROW) markets, including the preparation of scientific documents, justifications and responses to analytical method-related regulatory queries in accordance with applicable ICH guidelines and regional regulatory requirements.
This will close in 0 seconds
Director (Board Member of Finoso Management) - Finoso Pharma & Chief Technical Officer - Vivimed Labs
Dillip obtained his Master’s in Pharmaceutical & Pharmaceutical Technology from LM college of Pharmacy, Ahmedabad, Gujarat India. He has about 15 plus years of work experience in Research & Development, Business Development and Manufacturing Plant operations.
He worked in the Innovation &Generic Pharmaceutical industry for over 15 years, handling product and process development activities. During this time, he was responsible for developing several solid and liquid dosage form products and got several ANDAs approved by the US FDA, MHRA, Health Canada, TGA etc. After leading formulation Development teams in companies like ZydusCadila, Mylan Laboratories Ranbaxy Research Laboratory, India & Dr.Reddy’s Laboratories he moved to Aizant for setting up In house products portfolio. Under his visionary leadership Aizant filed & got approval for multiple complex generic and NCE-1 products.After his successful stint at Aizant, he took the responsibility asPresident R&D and Operations at Optimus pharma where he played important role in reforming the business model, under his visionary and vibrant leadership Optimus pharma observed the peaks of growth. Optimus was amongst few first Indian companies to launch & get approval for anti-corona Favipiravir Tablets.
He has rich experience that encompasses activities from formulation development to product approvals for the US, Europe and other regulated markets. He managed entire product development program from molecule selection, development strategy, risk assessment analysis, infringement analysis and regulatory filings of generic products. He has several patents, at various stages, to his credit. He was exposed to generic product development from Para I to Para IV filings and he has substantial experience in filing NDAs as well.
Dillip has hands on experience in developing formulations of Antidepressant, Anti-allergic, Antiviral, Anti-diabetic and Cardiovascular drugs. His research projects included development of Para IV / modified release / sustained release generic formulations based on matrix / palletization / osmotic delivery technologies for oral solid dosage forms. He has several publications and research papers to his credit.
He joined Finoso Pharma in Aug 2020 and has been running the company successfully ever since as its Director& CTO.
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
This will close in 0 seconds
Holds Master’s Degree, leading Quality Assurance, Regulatory Affairs and Project Management Teams in Finoso Pharma Private Limited. Pharmaceutical Quality and Regulatory Professional with over two decades of enriched experience, with proven success in establishing overall Quality Management Systems and well versed with cGMPs, US, EU and HC Guidelines, ICH Quality Standards and GLPs.
Faced successfully multiple audits/inspections conducted by local, national and international regulatory authorities like USFDA (3), MHRA (3), Ukraine (1), Health Canada (1), TGA (1) and EU (1).
Led the cross functional teams effectively for getting Local GLP and EU GMP approvals for Finoso Pharma Private Limited.
Experienced in aspects of Development Quality Assurance, Formulation Development, Analytical Development, Quality Management System, Audit & Compliance, Vendor Qualifications, Quality Documentation, and has comprehensive understanding and knowledge about pharmacopoeias and current International Quality and Regulatory requirements.
Having full knowledge about cGMP Manufacturing Site Quality Assurance, Quality Control and Production Operations. Handled quality aspects of many technology transfer projects, site transfer projects and commercial manufacturing for different markets.
Handled several generic product dossier compilations and registrations in various markets like US, EU, UK, Canada and ROW countries.
Driven multiple development projects and turn-key projects for different markets, ensured timely project completions and submissions of dossiers in regulatory authorities.
Earlier to Finoso, was associated with Evertogen Life Sciences Limited, Getz Pharma Private Limited, Enaltec Labs Limited, Aurigene Discovery Technologies Limited, Dr. Reddy’s Laboratories Limited.
This will close in 0 seconds
Accounts Director l Head of Purchase Department l Financial Management l Strategic Procurement , Leads the company's accounting and Procurement functions, driving financial accuracy, cost efficiency, and Strategic purchasing to support business growth, With a strong focus on financial management, budgetary control, vendor relationship management and Procurement planning and ensure transparency, accountability and operational efficiency.
Ensures Financial Planning, expense monitoring, Purchase coordination, supplier evaluation, cost optimization and internal financial controls. By aligning Procurement strategies with organizational objectives,  Supports the timely availability of quality materials, effective resource utilization, and cost-effective business operations
This will close in 0 seconds
With more than 22 years in regulated pharmaceutical markets, Dhaval Samani brings a rare combination of regulatory depth and commercial instinct to Finoso's global partnerships. An In/Out-licensing specialist, he has built his career across Market Access, GxP compliance, CDMO Partnerships & Strategic Licensing, working across India, the US, EU, UK, Southeast Asia, LATAM, MENA, CIS, Africa and China.
His track record includes driving Supplier Quality, Factory Set-Up, GxP Quality & Compliance, GMP certification programmes (PIC/S, EU, USFDA, MHRA, WHO PQ, EAEU and others), Marketing Authorizations and Market-Access strategies, delivered in close alignment with cross-functional teams.
As Director of Business Development, he builds long-term, value-driven partnerships with pharmaceutical companies, innovators and dossier owners seeking a trusted partner for development, manufacturing, Technology transfer and EU-ready dossier licensing and supply.
This will close in 0 seconds
Mahesh Annam is an accomplished pharmaceutical formulation development leader with 18 years of experience in product innovation, development, and commercialization. His expertise spans formulation design, scale-up, technology transfer, commercial launch, and lifecycle management of solid oral dosage forms, including oncology, and liquid oral formulations, with exposure to semi-solid and ophthalmic formulations. He was previously associated with Aizant Drug Research Solutions, LAURUS LABS, TEIFENBACHER GROUP (formerly AET Labs), and Macleods Pharmaceuticals, gaining experience across CRO, CDMO and proprietary product development environments.
Mahesh has successfully led hybrid application programs and contributed to the filing of approximately 8 NCE-1 products for the US market and around 15 products for Europe and the UK. His experience includes low-dose products with multiple strengths and fixed-dose combinations (FDCs). He also holds a patent for a drug product developed for the US market, reflecting his contribution to pharmaceutical innovation and differentiated product development.
He possesses strong expertise in regulatory-driven development for US, CA and Europe, supporting product portfolio expansion across the UK, ASEAN, LATAM, Asia-Pacific, CIS, and GCC markets. His capabilities include addressing technical and scientific regulatory queries in alignment with market-specific requirements. Mahesh holds a Master’s degree in Pharmacy (Pharmaceutics) from Osmania University and an MBA (Technology Management) from Osmania University, combining strong scientific expertise with strategic management skills to drive product development, process development, Technology Transfer, regulatory compliance, and commercialization
This will close in 0 seconds
Pharmaceutical R&D Director | Formulation Development | Global Regulatory Strategy | Product Innovation & Commercialization
Leads the strategic development of innovative, high-quality, and cost-effective pharmaceutical products, from concept development through commercialization. With expertise in formulation development, process optimization, analytical development, and regulatory compliance, the role supports the development of robust pharmaceutical products that meet global quality and regulatory requirements.
This will close in 0 seconds
